conv.

← The whole story
Health
FDA panel votes on Grail's Galleri multi-cancer blood test

Molecular and Clinical Genetics Panel weighs clinical evidence

6 Today 9:44 AM · 13h ago · 1 article · 1 post · 2 sources · development 6 of 6

Quartz identifies the reviewing body as the FDA's Molecular and Clinical Genetics Panel, which is assessing Galleri's clinical evidence with Medicare coverage potentially following approval.

Molecular and Clinical Genetics Panel weighs clinical evidence
STAT News

Grail Inc. Maker of the Galleri multi-cancer blood testFDA Molecular and Clinical Genetics Panel Independent advisory panelVinay Prasad Former FDA biologics chiefWSJ Editorial Board Opinion commentator

The whole story articlesposts the bright band is this development · numbered dots are the others · click one to jump

Peak 6 pieces in one hour at Today, 9 AM; 27 pieces over 3 days (18 articles · 9 posts) Sep 20, 4 PM — 1 piece · 1 article — Newswires 1Sep 20, 5 PM — quietSep 20, 6 PM — quietSep 20, 7 PM — quietSep 20, 8 PM — quietSep 20, 9 PM — quietSep 20, 10 PM — quietSep 20, 11 PM — quietSep 21, 12 AM — quietSep 21, 1 AM — quietSep 21, 2 AM — quietSep 21, 3 AM — quietSep 21, 4 AM — 1 piece · 1 article — Newswires 1Sep 21, 5 AM — quietSep 21, 6 AM — quietSep 21, 7 AM — quietSep 21, 8 AM — quietSep 21, 9 AM — quietSep 21, 10 AM — quietSep 21, 11 AM — quietSep 21, 12 PM — quietSep 21, 1 PM — 1 piece · 1 article — Newswires 1Sep 21, 2 PM — quietSep 21, 3 PM — 3 pieces · 3 articles — Google News 3Sep 21, 4 PM — quietSep 21, 5 PM — quietSep 21, 6 PM — quietSep 21, 7 PM — quietSep 21, 8 PM — quietSep 21, 9 PM — quietSep 21, 10 PM — quietSep 21, 11 PM — quietYesterday, 12 AM — quietYesterday, 1 AM — quietYesterday, 2 AM — quietYesterday, 3 AM — quietYesterday, 4 AM — quietYesterday, 5 AM — quietYesterday, 6 AM — quietYesterday, 7 AM — quietYesterday, 8 AM — quietYesterday, 9 AM — quietYesterday, 10 AM — quietYesterday, 11 AM — quietYesterday, 12 PM — quietYesterday, 1 PM — quietYesterday, 2 PM — quietYesterday, 3 PM — quietYesterday, 4 PM — quietYesterday, 5 PM — quietYesterday, 6 PM — quietYesterday, 7 PM — quietYesterday, 8 PM — quietYesterday, 9 PM — quietYesterday, 10 PM — quietYesterday, 11 PM — quietToday, 12 AM — quietToday, 1 AM — quietToday, 2 AM — quietToday, 3 AM — quietToday, 4 AM — quietToday, 5 AM — 5 pieces · 2 articles · 3 posts — Mastodon 3, Newswires 2Today, 6 AM — 1 piece · 1 post — Mastodon 1Today, 7 AM — quietToday, 8 AM — 2 pieces · 2 articles — Newswires 2Today, 9 AM — 6 pieces · 4 articles · 2 posts — Newswires 4, Mastodon 2Today, 10 AM — quietToday, 11 AM — quietToday, 12 PM — quietToday, 1 PM — quietToday, 2 PM — quietToday, 3 PM — quietToday, 4 PM — 2 pieces · 1 article · 1 post — Mastodon 1, Newswires 1Today, 5 PM — 1 piece · 1 article — Newswires 1Today, 6 PM — 4 pieces · 2 articles · 2 posts — Google News 2, Mastodon 2Today, 7 PM — quietToday, 8 PM — quietToday, 9 PM — quietToday, 10 PM — quiet 1234–6
1WSJ editorial board urges FDA to clear…2Grail shares surge 33% on FDA meeting…3FDA's outside expert panel meets to vote…4–6Molecular and Clinical Genetics Panel…
Sep 21yesterdaytodaynow · 11:22 PM ET

What was reported 1 claim about this development

  1. 1 outlet FDA advisers are voting on Grail's multicancer blood test as Medicare coverage hangs in the balance

    first by Quartz, 13h ago

What people said 2 voices · verbatim

All 6 developments of FDA panel votes on Grail's Galleri multi-cancer blood test →

NewswiresGoogle NewsMastodon